Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 7:20 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2353–2376 of 6,038 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obesity Clear all

Conditions: Type 2 Diabetes, Obesity, Bariatric Surgery
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Weight Loss, Schizophrenia
Interventions: Alpha Lipoic Acid; Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Weight Loss, Men, Lifestyle Risk Reduction, Cardiovascular Diseases, Obesity
Interventions: Self-guided lifestyle intervention; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years to 35 Years · Male only
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Sleep Apnea, Obstructive, Obesity
Interventions: Propofol Alone, Propofol+Benzo/Opioids; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obesity, Childhood, Binge Eating, Sleep, Self-regulation
Interventions: Sleep restriction, Sleep extension; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 8 Years to 12 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania • Providence, Rhode Island

Conditions: Obesity
Interventions: Phosphatidylcholine Deoxycholate, Saline; Drug
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 25 Years to 70 Years · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Isolated Impaired Fasting Glucose
Interventions: Low-calorie diet, Routine dietary and physical activity habits; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 35 Years to 65 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Obesity, Overweight, Chronic Weight Management, Type 2 Diabetes Mellitus
Interventions: ASC30 tablets A1, Placebo; Drug
Lead sponsor: Ascletis Pharma (China) Co., Limited; Industry
Eligibility: 18 Years and older
Enrollment: 1,560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 84
States / cities: Birmingham, Alabama • Huntsville, Alabama • Peoria, Arizona + 80 more

Conditions: Bariatric Surgery, Sleeve Gastrectomy, Obesity
Interventions: Dietary habits plan; Behavioral
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 22 Years to 62 Years
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Pain, Osteoarthritis, Obesity and Overweight, Inactivity
Interventions: MORPH, Measurement Only; Behavioral
Lead sponsor: Wake Forest University; Other
Eligibility: 65 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Infant Development, Obesity, Childhood, Diabetes, Childhood-Onset
Interventions: Pre-Pregnancy BMI; Other
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Obesity
Interventions: Brief Counseling, REE Assessment; Behavioral · Device
Lead sponsor: Microlife; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Timeline: Started 2007
U.S. locations: 1
States / cities: Mt. Dora, Florida

Conditions: Obesity, Body Composition
Interventions: Smartwatch activity and body composition monitor, General guidance on recommended exercise; Device · Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 99 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Metabolic Syndrome, Hypogonadism
Interventions: Testosterone gel, Placebo for testosterone gel; Radiation · Drug
Lead sponsor: McGuire Research Institute; Other
Eligibility: 20 Years to 65 Years · Male only
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Healthy Volunteer
Interventions: ABBV-295, Levonorgestrel/Ethinyl Estradiol; Drug
Lead sponsor: AbbVie; Industry
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Anaheim, California • Grayslake, Illinois

Conditions: Gestational Diabetes, Obesity
Interventions: Lifestyle Counseling; Behavioral
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Oakland, California

Conditions: Loss-of-control Eating, Obesity/Overweight
Interventions: Naltrexone and Bupropion medication, Behavioral Weight Loss, Placebo; Drug · Behavioral · Other
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 92 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Breast Cancer, Overweight or Obesity
Interventions: Contrave, Behavioral Weight Loss; Drug · Behavioral
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older · Female only
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Insulin Resistance, Insulin Sensitivity, Obesity, Inflammation
Interventions: Not listed
Lead sponsor: Stanford University; Other
Eligibility: 30 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2026
U.S. locations: 1
States / cities: Stanford, California

Conditions: Pain, Postoperative
Interventions: Transdermal Lidocaine Patch, Transdermal Hydrocolloid Placebo Patch; Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 59 Years · Female only
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Healthy, Obesity, Postmenopausal
Interventions: communication intervention, exercise intervention; Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 55 Years to 75 Years · Female only
Enrollment: 71 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Obesity, Binge Eating Disorder
Interventions: Guided Self-Help, Pure Self-Help; Behavioral
Lead sponsor: Francine Rosselli; Other
Eligibility: 18 Years to 22 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 2
States / cities: Manchester, Connecticut • Middletown, Connecticut

Conditions: Obesity Type 2 Diabetes Mellitus, Obesity (Disorder)
Interventions: GLP-1 Therapy; Drug
Lead sponsor: University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 2
States / cities: Columbia, South Carolina • Greenville, South Carolina

Conditions: Obesity, Food Labeling, Health Behavior, Diet
Interventions: Subsidy, Tax, Tax and subsidy; Behavioral
Lead sponsor: Cornell University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 221 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2011
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Relationship Between Changes in Gut Hormones After Gastric Bypass and Gastric Banding and Improvements in Diabetes

An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia

A Novel Approach to Reducing Adiposity Among Young Men

Propofol vs Propofol + Benzo/Opiates in High Risk Group

Project REST: Regulation of Eating and Sleep Topography

A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal

Low-calorie Diet in Isolated Impaired Fasting Glucose

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Role of Dietary Habits in Efficacy of Bariatric Surgery - Study C

A Mobile Intervention to Reduce Pain and Improve Health-III

Breastmilk in Response to a Bout of Exercise

Clinical Observation of Implementing the MedGem Into a Medical Specialty Practice

Body Composition and Exercise to Prevent Muscle Loss With GLP1 Agonist Treatment

Effect of Testosterone Replacement on Insulin Resistance

A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives

Diabetes Prevention Strategies in Women With Gestational Diabetes Mellitus (GDM)

Pharmacological and Behavioral Treatment After Bariatric Surgery: Acute (Stage 1)

Adaptive Nutrition and Exercise Weight Loss (A-NEW) Study

Adaptive Immune Response in Visceral and Subcutaneous Fat: Role in Human Insulin Resistance

The OBstetric Lidocaine Patch (OBLido) Trial

Communication & Peer Support Effects on Physical Activity in Overweight Postmenopausal Women

Binge Eating Self-help Treatment for University Students

Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy

Nudging Nutrition With Monetary Incentives Environmental Cues